Description
Dapitant, also known as RPR100893, is a potent and selective NK1 receptor antagonist both in vitro and in vivo, and exhibits high affinity for guinea pig and human NK1 receptor.Dapitant was developed as a potential drug for the acute treatment of migraine. However, in clinical trials, it was not effective